Scinai Immunotherapeutics annual operating margin
2024
2025
Scinai Immunotherapeutics Operating Margin Growth & History (SCNI)
Scinai Immunotherapeutics's operating margin was −575.29% for fiscal 2025.
View full Scinai Immunotherapeutics company overviewScinai Immunotherapeutics annual operating margin history
| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −575.29% | +2219990.27 pp |
| 2024 | 2024-12-31 | −2,220,565.55% | — |
Scinai Immunotherapeutics quarterly operating margin
Q4.24
Q1.25
Q2.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | −466.52% | +707.28 pp |
| Q1 2026 | 2026-03-31 | −504.50% | −236.92 pp |
| Q2 2025 | 2025-06-30 | −1,173.80% | — |
| Q1 2025 | 2025-03-31 | −267.58% | — |
| Q4 2024 | 2024-12-31 | −1,098.54% | — |
Scinai Immunotherapeutics operating margin trends
Between the periods ended 2024-12-31 and 2025-12-31, Scinai Immunotherapeutics's operating margin increased from −2,220,565.55% to −575.29%, a change of +2219990.27 percentage points. The latest reported quarter, Q2 2026, shows −466.52%.
About the metric
What operating margin means
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
Calculation and source
How operating margin is calculated
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Scinai Immunotherapeutics source filings ↗